Condition: Neuroendocrine Tumors · Neuroendocrine Neoplasm · Neuroendocrine Tumor Grade 1 · Sponsor: University of Roma La Sapienza
This is a multicentre, controlled, observational prospective study on new biomarkers, as immune profiling, angiogenetic markers and circRNA from TEPs in the diagnosis and in the evaluation of treatment response in pulmonary and gastro-entero-pancreatic NENs.
This description comes directly from the study's public registry record.
Andrea M Isidori, MD, PhD · +390649970540 · andrea.isidori@uniroma1.it
Elisa M Giannetta, MD, PhD · +390649970540 · elisa.giannetta@uniroma1.it
Always discuss trial participation with your own doctor first.
| Andrea M Isidori | Rome, Italy, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04464122